Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model

被引：44
|
作者：
Alici, Evren [1 ]
Konstantinidis, Kyriakos V. [1 ]
Sutlu, Tolga [1 ]
Aints, Alar [1 ]
Gahrton, Gosta [1 ]
Ljunggren, Hans-Gustaf [1 ]
Dilber, M. Sirac [1 ]
机构：
[1] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Med, Ctr Infect Med, S-14186 Stockholm, Sweden
来源：
EXPERIMENTAL HEMATOLOGY | 2007年 / 35卷 / 12期
关键词：
D O I：
10.1016/j.exphem.2007.08.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Objective. Despite advances in autologous stem cell transplantation and chemotherapy, multiple myeloma (MM) remains an incurable disease. Due to the role of natural killer (NK) cells in host resistance against several tumors, it is of interest to explore the anti-MM activity of NK cells. For this reason, we aimed to determine if NK cells provide anti-MM activity following interleukin-2 (IL-2) administration, and if ex vivo activated and intravenously administered NK cells prolong survival in MM-bearing C57BL/KaLwRij mice. Methods. The anti-MM effect of IL-2 was tested by intraperitoneal injection into the 5T33MM-inoculated mice. Subsequently, in vivo effector cell depletions were performed by administration of anti-NK1.1 or anti-CD8 monoclonal antibodies. Finally, magnetically separated and activated NK cells from splenocytes of C57BL/KaLwRij mice were adoptively transferred to tumor-bearing mice in conjunction with IL-2 treatment. Results. IL-2 administration into MM-bearing mice significantly prolonged their survival. This effect was diminished by in vivo depletion of NK cells. Adoptive transfer of activated NK cells showed a significant in vivo anti-MM effect that was dependent on cell dose. Biodistribution of the marked adoptively transferred NK cells correlated with MM cells' homing sites. Conclusion. These data suggest that activated NK cells have a promising potential in adoptive immunotherapy for MM. (C) 2007 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc.
引用
收藏
页码：1839 / 1846
页数：8
相关论文
共 50 条
  • [41] In Vitro Anti-Myeloma Activity of the Multitargeted Kinase Inhibitor Midostaurin in the Context of Heterotypic Cocultures of Myeloma Cells with Nonmalignant Microenvironmental Accessory Cells
    Lawasut, Panisinee
    Jacobs, Hannah M.
    Delmore, Jake E.
    Negri, Joseph
    McMillin, Douglas W.
    Weisberg, Ellen L.
    Griffin, James D.
    Richardson, Paul G.
    Anderson, Kenneth C.
    Mitsiades, Constantine S.
    BLOOD, 2011, 118 (21) : 1260 - 1260
  • [42] NATURAL-KILLER CELL-ACTIVITY IN PATIENTS WITH MULTIPLE-MYELOMA
    OGMUNDSDOTTIR, HM
    CANCER DETECTION AND PREVENTION, 1988, 12 (1-6): : 133 - 143
  • [43] Activated CMRF-56 selected blood dendritic cells: A potential anti-myeloma vaccine
    Freeman, Jennifer L.
    Vari, Frank
    Hart, Derek N. J.
    BLOOD, 2007, 110 (11) : 739A - 740A
  • [44] ACTIVATED NATURAL KILLER CELLS WITHSTAND THE LOW GLUCOSE CONCENTRATIONS FOUND IN THE BONE MARROW OF MULTIPLE MYELOMA PATIENTS
    Ehlers, Femke A. I.
    Mahaweni, Niken M.
    Olieslagers, Timo I.
    Bos, Gerard
    Wieten, Lotte
    HLA, 2019, 93 (05) : 274 - 274
  • [45] NATURAL POLYPHENOLS ANTAGONIZE THE ANTI-MYELOMA ACTIVITY OF PROTEASOME INHIBITOR BORTEZOMIB BY DIRECT CHEMICAL INTERACTION
    Kim, T.
    Park, J.
    Oh, B.
    Min, H. J.
    Jeong, T. -S.
    Lee, J. H.
    Suh, C.
    Cheong, J. -W.
    Kim, H. J.
    Yoon, S. -S.
    Park, S. B.
    Lee, D. S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 417 - 417
  • [46] NKG2A Expression Is Not per se Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an In Vitro System Mimicking the Tumor Microenvironment
    Mahaweni, Niken M.
    Ehlers, Femke A., I
    Sarkar, Subhashis
    Janssen, Johanna W. H.
    Tilanus, Marcel G. J.
    Bos, Gerard M. J.
    Wieten, Lotte
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [47] Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cells
    Barber, A.
    Meehan, K. R.
    Sentman, C. L.
    GENE THERAPY, 2011, 18 (05) : 509 - 516
  • [48] Selinexor Enhances Natural Killer Cell Function Against Multiple Myeloma Cells
    Fisher, Jack G.
    Doyle, Amber D. P.
    Graham, Lara V.
    Forconi, Francesco
    Cragg, Mark S.
    Walker, Christopher J.
    Khakoo, Salim I.
    Blunt, Matthew D.
    BLOOD, 2023, 142
  • [49] ANTIGEN PRESENTING CELL-MEDIATED EX VIVO EXPANSION OF HUMAN UMBILICAL CORD BLOOD CELLS YIELDS SIGNIFICANT EXPANSION OF NATURAL KILLER CELLS WITH ANTI-MYELOMA ACTIVITY
    Shah, N. J.
    Ku, S.
    Xing, D.
    Lee, D.
    Cooper, L.
    Tzou, B.
    Decker, W.
    Li, S.
    Robinson, S.
    Yang, H.
    Parmar, S.
    Tung, S.
    Bollard, C.
    Shpall, E. J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S210 - S210
  • [50] Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cells
    A Barber
    K R Meehan
    C L Sentman
    Gene Therapy, 2011, 18 : 509 - 516
12345